ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0747

Association Between Podocyte IgG and Circulating Antinephrin in Diffuse Podocytopathy in Adults

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Therapeutics

Authors

  • Wang, Qiyu, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Ghasemi, Maryam, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Watts, Andrew James Baxter, VA Boston Healthcare System, West Roxbury, Massachusetts, United States
  • Mount, David B., Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Weins, Astrid, Brigham and Women's Hospital, Boston, Massachusetts, United States
Background

Circulating anti-nephrin antibody (Ab) has been detected in 40~60% adult patients (pts) with diffuse podocytopathy (DP). Punctate podocyte IgG, a tissue marker for anti-nephrin Ab, was observed in ~60% of DP at our institution. We evaluated the association between tissue and serological markers of anti-nephrin mediated injury and between circulating Ab and disease activity.

Methods

We reviewed biopsies of newly diagnosed DP with concurrent serum Ab sampling within 15 days from 2018-2025 at our institution. Serum Ab was tested by anti-nephrin ELISA as previously described. A threshold of 139U/mL was used to define positivity based on healthy controls. Podocyte IgG was adjudicated by 2 pathologists by routine immunofluorescence (IF); microscopy for IgG-nephrin colocalization was performed in select cases.

Results

Of 16 pts 15 had nephrotic syndrome at biopsy and 1 nephrotic-range proteinuria. Median time between biopsy and serum sampling was 0 days (range -7—15) (Table 1). All pts (8/8) with +podocyte IgG and 38% (3/8) with -podocyte IgG were positive (pos) for serum Ab (Figure 1). Of the 3 pts with discordant biopsy-serum testing, IF with IgG-nephrin dual staining was pos in 2, and negative (neg) in 1. 8 serologically pos pts underwent follow-up testing at disease remission: 6/8 (75%) had neg serum anti-nephrin, while 2/8 (25%) remained pos.

Conclusion

Podocyte IgG correlates with pos serum Ab in DP during active disease in majority of pts. Reflex dual IgG-nephrin staining increased detection and may serve as a sensitive adjunct diagnostic. Persistent pos serum anti-nephrin in the 2 pts at remission was unexplained and requires further study.

Funding

  • Private Foundation Support

Digital Object Identifier (DOI)